Diagnostic Kits/Data, narratives and tools produced by the Kits' sector: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
Line 72: Line 72:
|
|
|}
|}
Definition List
*'''Patent Holders'''
*: (exclusive licensee)
* key patents
*: 5753441, 6051379,
* products
*: prod ($3120)


= References =
= References =

Revision as of 18:16, 23 November 2009

Types of inputs for kits

Genetic Diagnostic Case Studies

The following are summaries of IP and commercialization information of commercially available diagnostic kits. A subset of this list will be developed into more extensive case studies. The old spreadsheet form of this information is available here.

Breast and Ovarian Cancer

BRCA1

At a glance:

Gene BRCA1
Patent Holders Myriad Genetics
Key Patents 5753441, 6051379
Other Patents
Licenses exclusive
US Test providers 1
Test BRACAnalysis ($3120) - includes BRCA1 & BRCA2
Test cost $3120

BRCA2

  • Patent Holders
    Myriad Genetics (exclusive licensee)
  • key patents
    5753441, 6051379,
  • products
    BRACAnalysis ($3120) - includes BRCA1 & BRCA2

template

Empty table

Gene
Patent Holders
Key Patents
Other Patents
Licenses
US Test providers
Test
Test cost

Definition List

  • Patent Holders
    (exclusive licensee)
  • key patents
    5753441, 6051379,
  • products
    prod ($3120)

References

Main Page Diagnostic_Kits

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Diagnostic_Kits/Data,_narratives_and_tools_produced_by_the_Kits%27_sector&oldid=5398"